Company news
Pulse Biosciences, Inc news in 2023
Pulse Biosciences, Inc's news releases, calls and decks from 2023, newest first.
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
December 19, 2023
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
November 20, 2023
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
November 14, 2023
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
November 12, 2023
UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call
November 9, 2023
Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023
October 29, 2023
Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery
October 23, 2023
Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study
October 1, 2023
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
September 28, 2023
Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
September 26, 2023
Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
September 6, 2023
Pulse Biosciences Clarifies Details of Recent S-3 Filing
August 23, 2023
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
August 9, 2023
Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
July 26, 2023
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
May 17, 2023
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
May 10, 2023
Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
May 2, 2023
Pulse Biosciences Announces $65 Million Private Placement
April 30, 2023
Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
April 26, 2023
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
March 29, 2023
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
March 1, 2023
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
February 1, 2023
Calls in 2023
- Pulse Biosciences (NASDAQ:PLSE) Q3 2023 Earnings Call
Nov 13, 2023
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q2 2023 Earnings Call
Aug 10, 2023
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q1 2023 Earnings Call
May 11, 2023
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q4 2022 Earnings Call
Mar 30, 2023
Transcript
Decks in 2023
- Investor Presentation (July 2023)
Investor deck · 20 slides · Jul 20, 2023